These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1226 related items for PubMed ID: 9721472
21. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, Mecucci C, Reisner Y, Martelli MF. J Clin Oncol; 2005 May 20; 23(15):3447-54. PubMed ID: 15753458 [Abstract] [Full Text] [Related]
22. Favorable outcome for infant acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Jacobsohn DA, Hewlett B, Morgan E, Tse W, Duerst RE, Kletzel M. Biol Blood Marrow Transplant; 2005 Dec 20; 11(12):999-1005. PubMed ID: 16338622 [Abstract] [Full Text] [Related]
23. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O. J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049 [Abstract] [Full Text] [Related]
24. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M. Bone Marrow Transplant; 2004 Oct 15; 34(8):721-7. PubMed ID: 15322568 [Abstract] [Full Text] [Related]
25. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Oyekunle AA, Kröger N, Zabelina T, Ayuk F, Schieder H, Renges H, Fehse N, Waschke O, Fehse B, Kabisch H, Zander AR. Bone Marrow Transplant; 2006 Jan 15; 37(1):45-50. PubMed ID: 16258531 [Abstract] [Full Text] [Related]
26. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P. Cancer J Sci Am; 1996 Jan 15; 2(6):330-4. PubMed ID: 9166553 [Abstract] [Full Text] [Related]
27. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia]. Sun J, Meng FY, Liu QF, Xu D, Xu B, Liu XL. Ai Zheng; 2003 Dec 15; 22(12):1321-4. PubMed ID: 14693060 [Abstract] [Full Text] [Related]
28. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. Baker KS, Loberiza FR, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ. J Clin Oncol; 2005 Oct 01; 23(28):7032-42. PubMed ID: 16145067 [Abstract] [Full Text] [Related]
29. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Arellano ML, Langston A, Winton E, Flowers CR, Waller EK. Biol Blood Marrow Transplant; 2007 Jan 01; 13(1):116-23. PubMed ID: 17222760 [Abstract] [Full Text] [Related]
30. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation. Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F, Italian Pediatric Group for Bone Marrow Transplantation. Bone Marrow Transplant; 2001 Jul 01; 28(2):131-6. PubMed ID: 11509930 [Abstract] [Full Text] [Related]
31. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia. Jacobsohn DA, Hewlett B, Ranalli M, Seshadri R, Duerst R, Kletzel M. Bone Marrow Transplant; 2004 Nov 01; 34(10):901-7. PubMed ID: 15361908 [Abstract] [Full Text] [Related]
32. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO). Dini G, Boni L, Abla O, Uderzo C, Polchi P, Locatelli F, Di Bartolomeo P, Arcese W, Iori AP, Rossetti F. Bone Marrow Transplant; 1994 Jun 01; 13(6):771-6. PubMed ID: 7920313 [Abstract] [Full Text] [Related]
33. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years. Huisman C, Meijer E, Petersen EJ, Lokhorst HM, Verdonck LF. Biol Blood Marrow Transplant; 2008 Feb 01; 14(2):181-6. PubMed ID: 18215778 [Abstract] [Full Text] [Related]
34. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Biol Blood Marrow Transplant; 2007 Sep 01; 13(9):1083-94. PubMed ID: 17697971 [Abstract] [Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
36. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia]. Liu QF, Sun J, Xu D, Zhang Y, Fan ZP, Wei YQ, Meng FY, Zhou SY. Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct 01; 24(10):1117-9. PubMed ID: 15485779 [Abstract] [Full Text] [Related]
37. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Matsuyama T, Kojima S, Kato K. Bone Marrow Transplant; 1998 Jul 01; 22(1):21-6. PubMed ID: 9678791 [Abstract] [Full Text] [Related]
38. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease. Yanada M, Naoe T, Iida H, Sakamaki H, Sakura T, Kanamori H, Kodera Y, Okamoto S, Kanda Y, Sao H, Asai O, Nakai K, Maruta A, Kishi K, Furukawa T, Atsuta Y, Yamamoto K, Tanaka J, Takahashi S. Bone Marrow Transplant; 2005 Nov 01; 36(10):867-72. PubMed ID: 16113659 [Abstract] [Full Text] [Related]
39. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Biol Blood Marrow Transplant; 2008 May 01; 14(5):568-75. PubMed ID: 18410899 [Abstract] [Full Text] [Related]
40. Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers. Miniero R, Busca A, Bonetti F, Giorgiani G, Zecca M, Berger M, Incarbone E, Vassallo E, Perotti C, Locatelli F. Bone Marrow Transplant; 1998 Dec 01; 22 Suppl 5():S33-6. PubMed ID: 9989887 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]